Rosa David A, CEO and President of NeuroOne Medical Technologies Corp ($NMTC), made one open market purchase of company shares worth $50,000 in the last year, with the most recent on April 4, 2025. This ranks 2,998th among 4,983 insiders averaging $1.46 million across 3.29 transactions. No open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2458 | $0.78 | 1,080,132.0000 | 50,331,155 | 0.23% | 0.00% |
| Feb. 18, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 71325 | $0.68 | 1,082,590.0000 | 50,331,155 | 6.18% | 0.14% |
| Dec. 31, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2458 | $0.76 | 1,153,915.0000 | 40,152,873 | 0.21% | 0.01% |
| Sept. 30, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2458 | $0.89 | 1,156,373.0000 | 48,604,996 | 0.21% | 0.01% |
| June 30, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2458 | $0.68 | 1,158,831.0000 | 31,111,786 | 0.21% | 0.01% |
| April 17, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | A | Option to Purchase Common Stock | 750000 | $0.00 | 750,000.0000 | 31,111,786 | 9999.99% | 2.41% |
| April 4, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | P | Common Stock | 100000 | $0.50 | 1,161,289.0000 | 31,111,786 | 9.42% | 0.32% |
| March 31, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2458 | $0.85 | 1,061,289.0000 | 30,880,415 | 0.23% | 0.01% |
| Feb. 18, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 71325 | $1.16 | 1,063,747.0000 | 30,880,415 | 6.28% | 0.23% |
| Feb. 14, 2025 | BioRestorative Therapies, Inc. | $BRTX | Rosa David A | Not found | A | Stock Option | 52632 | $0.00 | 174,796.0000 | 7,763,932 | 43.08% | 0.68% |
| Jan. 31, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.15 | 1,135,072.0000 | 30,880,415 | 0.20% | 0.01% |
| Dec. 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 4697 | $0.83 | 1,137,311.0000 | 26,762,392 | 0.41% | 0.02% |
| Nov. 30, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.62 | 1,142,008.0000 | 26,762,392 | 0.20% | 0.01% |
| Oct. 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.97 | 1,144,247.0000 | 26,762,392 | 0.20% | 0.01% |
| Sept. 30, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 4697 | $0.99 | 1,146,486.0000 | 27,352,660 | 0.41% | 0.02% |
| Aug. 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.80 | 1,151,183.0000 | 27,352,660 | 0.19% | 0.01% |
| July 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.75 | 1,153,422.0000 | 27,352,660 | 0.19% | 0.01% |
| June 30, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 4697 | $0.80 | 1,155,661.0000 | 25,910,478 | 0.40% | 0.02% |
| May 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.93 | 1,160,358.0000 | 25,910,478 | 0.19% | 0.01% |
| April 30, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.13 | 1,162,597.0000 | 25,910,478 | 0.19% | 0.01% |
| April 21, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 19673 | $1.15 | 1,164,836.0000 | 25,910,478 | 1.66% | 0.08% |
| March 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.20 | 1,184,509.0000 | 23,995,610 | 0.19% | 0.01% |
| March 12, 2024 | Healthcare Triangle, Inc. | $HCTI | Rosa David A | Director | A | Incentive Stock Option (Right To Buy) | 10000 | $0.00 | 34,000.0000 | 4,179,140 | 41.67% | 0.24% |
| Feb. 29, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.21 | 1,186,748.0000 | 23,995,610 | 0.19% | 0.01% |
| Feb. 18, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | A | Common Stock | 663497 | $0.00 | 1,188,987.0000 | 23,995,610 | 126.26% | 2.77% |
| Feb. 13, 2024 | BioRestorative Therapies, Inc. | $BRTX | Rosa David A | Not found | A | Stock Option | 79646 | $0.00 | 122,164.0000 | 4,218,347 | 187.32% | 1.89% |
| Jan. 31, 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.25 | 525,490.0000 | 23,995,610 | 0.42% | 0.01% |
| Dec. 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.58 | 527,729.0000 | 18,121,108 | 0.42% | 0.01% |
| Nov. 30, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.45 | 529,968.0000 | 18,121,108 | 0.42% | 0.01% |
| Nov. 9, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | A | Option to Purchase Common Stock | 526303 | $0.00 | 526,303.0000 | 18,121,108 | 9999.99% | 2.90% |
| Nov. 2, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.61 | 532,207.0000 | 18,121,108 | 0.42% | 0.01% |
| Oct. 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.90 | 534,446.0000 | 18,121,108 | 0.42% | 0.01% |
| Sept. 30, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.89 | 536,685.0000 | 17,578,871 | 0.42% | 0.01% |
| Aug. 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $0.85 | 538,924.0000 | 17,578,871 | 0.41% | 0.01% |
| July 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.02 | 541,163.0000 | 17,578,871 | 0.41% | 0.01% |
| June 30, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.20 | 543,402.0000 | 16,414,795 | 0.41% | 0.01% |
| May 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.21 | 545,641.0000 | 16,414,795 | 0.41% | 0.01% |
| April 30, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.54 | 547,880.0000 | 16,414,795 | 0.41% | 0.01% |
| April 21, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | A | Option to Purchase Common Stock | 91500 | $0.00 | 91,500.0000 | 16,414,795 | 9999.99% | 0.56% |
| April 21, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | A | Common Stock | 91500 | $0.00 | 550,119.0000 | 16,414,795 | 19.95% | 0.56% |
| March 31, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 2239 | $1.61 | 458,619.0000 | 16,230,997 | 0.49% | 0.01% |
| Feb. 3, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Rosa David A | CEO and President | F | Common Stock | 53750 | $1.47 | 460,858.0000 | 16,230,997 | 10.44% | 0.33% |